Drreddys Laboratories reported INR86.71B in Sales Revenues for its fiscal quarter ending in September of 2026.





Sales Change Date
ANI Pharmaceuticals USD 290.77M 24.77M Sep/2026
Aurora Cannabis CAD 67.55M 29.54M Jun/2026
Bayer EUR 10.05B 820M Sep/2026
Canopy Growth CAD 81.16M 9.91M Jun/2026
Cipla INR 74.04B 2.85B Sep/2026
Corcept Therapeutics USD 340.5M 84.35M Sep/2026
Drreddys Laboratories INR 86.71B 85.92B Sep/2026
GlaxoSmithKline GBP 8.89B 480M Sep/2026
Hikma Pharmaceutical USD 1.69B 863M Dec/2025
Lonza CHF 3.58B 63M Jun/2025
Novartis USD 14.52B 112M Sep/2026
Pacira USD 176.65M 15.75M Sep/2026
Phibro Animal Health USD 373.91M 10.02M Dec/2025
Prestige Brands USD 265.71M 15.91M Jun/2026
Richter Gedeon HUF 241.39B 21.19B Jun/2026
Sun Pharmaceuticals INR 161.99B 8.99B Sep/2026
Supernus Pharmaceuticals USD 226.8M 7.7M Sep/2026
Teva Pharmaceutical Industries USD 4.37B 8.3B Sep/2026